Portugal Ends Universal COVID-19 Shots for Kids—What Parents Need to Know

Portugal's Health Minister Ana Paula Martins recommended against universal COVID-19 vaccination for healthy children in 2021—a stance that now mirrors the country's current pediatric immunization policy. However, this alignment comes after the government initially pursued a broader vaccination strategy, and has now triggered a parliamentary inquiry into the government's handling of pandemic-era public health decisions.

Why This Matters

• Parliamentary hearings are scheduled to question Health Minister Martins, former Health Minister Marta Temido, and current and former directors-general of health about pediatric vaccination decisions.

• Current policy restricts COVID-19 vaccination to high-risk children only—matching Martins' 2021 recommendation but reversing the universal rollout that was implemented that year.

• The reversal raises questions about the original decision-making process and the data that informed the shift from universal to targeted vaccination.

The 2021 Advisory That Went Unheeded

When Ana Paula Martins served as president of the Portuguese Pharmaceutical Association (Ordem dos Farmacêuticos), she authored an official opinion in July 2021 at the request of then-Director-General of Health Graça Freitas. The document recommended that pediatric COVID-19 vaccination be reserved for children with compromised immune systems or debilitating pathologies, rather than rolled out universally.

Martins argued that the risks and uncertainties surrounding potential adverse effects warranted a more cautious approach for healthy children. For high-risk cases, she insisted vaccination should be decided individually, subject to two mandatory prerequisites: a pediatrician or family doctor's assessment of genuine necessity, and informed consent signed by legal guardians.

The Directorate-General of Health (DGS) chose a different path. In August 2021, Portugal began vaccinating children aged 12 and older. By December of that year, the program had extended to younger age groups—a broader rollout than many comparable European countries.

Policy Reversal: Current Alignment With Original Advice

The DGS has now restricted pediatric COVID-19 vaccination to high-risk children only: those with immunosuppression, active malignancy, HIV-AIDS, chronic organ failure, diabetes, or Down syndrome. The change made vaccination dependent on electronic prescription from a physician, effectively ending the universal recommendation.

Health authorities stated that while "vaccines are safe," the current evidence shows that "the cost-benefit ratio no longer justifies universalizing primary vaccination or seasonal boosters" for healthy children. The new policy closely mirrors the 2021 recommendation Martins made when it was not initially adopted.

What This Means for Residents

For parents and caregivers in Portugal, the practical takeaway is straightforward: COVID-19 vaccination is no longer universally recommended for children. If your child is healthy, national health authorities do not advise routine inoculation. If your child has a chronic condition or immunodeficiency, consult with a pediatrician or family doctor, who can issue a prescription if deemed medically necessary.

The shift also reflects broader trends across Europe. Several European countries have adopted more targeted vaccination strategies for children, focusing vaccination efforts on high-risk groups rather than universal programs. Portugal's current policy change aligns with these more selective approaches taken by other nations.

The Parliamentary Inquiry: Accountability and Transparency

The Portuguese Parliament has approved hearings to examine the government's handling of pediatric COVID-19 vaccination. Scheduled to testify are:

• Ana Paula Martins, current Health Minister and former pharmaceutical association president.

• Marta Temido, who served as Health Minister during the initial vaccine rollout period.

• Graça Freitas, Director-General of Health when the pediatric program was launched.

• Rita Sá Machado, current Director-General of Health.

The inquiry will examine why the DGS initially pursued a universal vaccination strategy despite the Pharmaceutical Association's cautionary recommendation in 2021, what data informed that decision, and the reasoning behind the subsequent policy adjustment to a targeted approach.

Broader Context: COVID-19 in Portugal

The pandemic has had significant public health impact in Portugal. While the disease proved particularly serious for older adults and individuals with underlying health conditions, children generally experienced milder outcomes. The evolving understanding of COVID-19's impact on different age groups has informed the reassessment of vaccination strategies.

The Rationale for Targeted Vaccination

The current approach of restricting pediatric vaccination to high-risk children reflects the principle of targeting resources where they provide the greatest benefit. Health authorities have indicated that for healthy children, COVID-19 typically presents as a mild illness, while children with specific chronic conditions or immunocompromise face elevated risks that vaccination can help mitigate.

What Comes Next

The parliamentary hearings will likely focus on key questions: What data and recommendations informed the DGS decision to pursue universal vaccination in 2021 despite the Pharmaceutical Association's caution? How were parents informed about the vaccination program? And what new evidence prompted the shift to a targeted approach?

For residents, the current guidance is clear. If your child is healthy, routine COVID-19 vaccination is not advised. If your child has a chronic condition, consult a physician. The inquiry will provide an opportunity for public understanding of how these important public health decisions were made.